Tumor markers in the assessment of malignant and benign pericardial effusion;Tumormarker im perikarderguss bei malignen und nichtmalignen perikardergüssen

Herz

Volumn 36, Issue 4, 2011, Pages 290-295

  Karatolios, K ^a   Maisch, B ^a   Pankuweit, S ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

CA 19 9 antigen; CA 72 4 antigen; Carcinoembryonic antigen; Pericardial effusion; Tumor markers

Indexed keywords

CARBOHYDRATE ANTIGEN; CARCINOEMBRYONIC ANTIGEN; NEURON SPECIFIC ENOLASE; SQUAMOUS CELL CARCINOMA ANTIGEN;

BENIGN PERICARDIAL EFFUSION; BENIGN TUMOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT PERICARDIAL EFFUSION; PERICARDIAL EFFUSION; REVIEW; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; FEMALE; HEART NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PERICARDIAL EFFUSION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 79959700013     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-011-3451-6     Document Type: Review

References (16)

1. Karatolios K, Maisch B (2007) Pericardiocentesis. Dtsch Med Wochenschr 132(33):1707-1710 (Pubitemid 47434867)
2. Koh KK et al (1994) Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis. Circulation 89(6):2728-2735 (Pubitemid 24173694)
3. Krikorian JG, Hancock EW (1978) Pericardiocentesis. Am J Med 65(5):808-814 (Pubitemid 9067007)
4. Maisch B et al (1994) Pericardioscopy and epicardial biopsy - new diagnostic tools in pericardial and perimyocardial disease. Eur Heart J 15(Suppl C):68-73 (Pubitemid 24266358)
5. Maisch B, Ristic A, Pankuweit S (2010) Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis 53(2):157-163
6. Maisch B, Ristic AD, Pankuweit S (2002) Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 23(19):1503-1508 (Pubitemid 35216716)
7. Maisch B et al (2002) Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J 23(20):1625-1631
8. Maisch B et al (2004) Guidelines on the diagnosis and management of pericardial diseases executive summary; the Task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. Eur Heart J 25(7):587-610 (Pubitemid 38478552)
9. Maisch B, Ristic AD, Seferovic P, Tsang TSM (2011) Interventional pericardiology. Pericardiocentesis, pericardioscopy, balloon pericardiotomy, and intrapericardial therapy. Springer, Berlin Heidelberg
10. Maisch B, Hufnagel G, Kölsch S et al (2004) Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins. Herz 29:624-636 (Pubitemid 39366052)
11. Meyers DG, Bouska DJ (1989) Diagnostic usefulness of pericardial fluid cytology. Chest 95(5):1142-1143 (Pubitemid 19137018)
12. Meyers DG, Meyers RE, Prendergast TW (1997) The usefulness of diagnostic tests on pericardial fluid. Chest 111(5):1213-1221
13. Rupp H, Rupp TP, Alter P et al (2010) Intrapericardial procedures for cardiac regeneration by stem cells. Need for minimal invasive access (AttachLifter) to the normal pericardial cavity. Herz 35:458-466
14. Seferovic PM et al (2003) Diagnostic value of pericardial biopsy: improvement with extensive sampling enabled by pericardioscopy. Circulation 107(7):978-983 (Pubitemid 36258720)
15. Szturmowicz M et al (1997) The role of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) evaluation in pericardial fluid for the recognition of malignant pericarditis. Int J Biol Markers 12(3):96-101 (Pubitemid 28029977)
16. Szturmowicz M et al (2005) Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis. Int J Biol Markers 20(1):43-49 (Pubitemid 40667599)